Skip to main content
Industry News
Amgen joins quest for R&D of coronavirus drug

Biotech pioneer Amgen is joining the hunt to find new drugs to treat the novel coronavirus, making the company the latest drugmaker to shift resources to the pandemic. Amgen has partnered with Adaptive Biotechnologies, mobilizing the two companies to discover a treatment.

Full Story: